The Melanoma Nursing Initiative – Home › Forums › Immunotherapy › Other › Pembro plus Epacadostat › Reply To: Pembro plus Epacadostat
June 10, 2018 at 4:40 am #4849
Expert NurseRajni Kannan
We were just discussing this last week. After years of ASCO having huge announcements of positive very influential findings things have slowed down. With the discovery of Ipilimumab and Nivolumab and the BRAF/MEK inhibitors we are almost at a plateau when it comes to new innovations. I am sure there are many more to come but at the moment especially front line clinical trials seems to be limited.